Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Rui Kang

Southwestern Medical Center

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 5, 2026 · JOURNAL ARTICLE

Engineering microRNAs as multimodal cancer therapeutics

Molecular Therapy — Nucleic Acids

This is a commentary describing a novel preclinical approach to engineer microRNAs as cancer therapeutics; it reports no original experimental data, effect sizes, or clinical outcomes.

Insufficient InformationLung Cancer Treatments and Mutations RNA Interference and Gene Delivery Daolin Tang

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support